As a libre user I can honestly say it has changed my lifeMahola, yes you are right everything is cash strapped these days. But from the Libra users I hear from indicate that has really helped their control. It would be good to get these on the NHS, even on a tempory loan basis. I would welcome the chance to use one of these for a month to understand what is going on, particularly during in the night and pesky dawn effects. I work full time and fatigue is a constant battle, I would die on my feet if I did routine 3am checks.
The NHS are strapped for cash as it is. I think we should be grateful for what we get for free already.
A Libre is not an essential part of diabetes care.
I would prefer the NHS spent its money on cancer treatments, resources and emergency care. And dietary advice - providing it was better advice than is provided now.
If more money is going to be spent on diabetes, i would prefer that it went on education.
I've done the maths on this, and it's not quite as good as you might think.I've worked out what finger pricking costs the NHS compared to Libre and Libre is actually CHEAPER. This is based on what we used to use compared to what we use now - loads of lancets and testing strips basically, vs sensors and a very scant number of testing strips. Not only that, given its ability to give such great data, surely people's long term health outcomes will be better, thus saving the NHS significantly longer term. I have seen a HbA1c reduce by 2.1% between quarterly hospital appointments, because the whole picture was obvious and could be quickly adjusted to. I know you're supposed to finger prick daily as well, but we have taken the view that if you trust a meter, why not trust the Libre, especially when the big result appears to be pretty good. My son finger pricks only sometimes: when a score of less than 4 is showing on the Libre reader, when he's in low 4's and the arrow is pointing down, or when he feels hypo. There is usually minimal difference. That's our choice and it works for us; not recommending this is right for everyone or indeed anyone else, of course. The stress of finger pricking was massive in our family and the Libre just changes that. Can't understand why it isn't available on the NHS really. Hopefully it will be one day. Doesn't seem fair that some people can't access this gem of a product.
I've done the maths on this, and it's not quite as good as you might think.
Firstly, don't start with the assumption that everyone fingerpricks between 8 and 10 times a day. That's a small minority, sadly.
The average number of fingerpricks done per day by T1s in the UK is a lot lower and the various studies that have been done (this one from 2009 looking at the UK and Denmark: http://www.sciencedirect.com/science/article/pii/S0168822709001946) suggested that the majority of T1s actually test no more than daily. This report (http://www.bmj.com/content/319/7202/83) which looked at glucose test strip prescription redemption showed that 16% probably didn't test and 20% didn't go through enough prescriptions to test once daily. This Swedish study showed that 43.9% of those who responded to the survey said they tested more than 4 times per day meaning 56% didn't. .
Once you take this into account, you realise that whilst getting this technology into the hands of those who want to use it would be brilliant, the bigger question is whether it would change behaviour of users. I've written about that before here: http://www.diabettech.com/diabetes/...-testing-behaviour-and-the-cost-implications/
In summary, yes this stuff is great, but the costs are much harder to drive out. On a one-to-one basis where a user is already using a lot of SMBG, it makes sense and the costs stack up effectively. Versus someone who doesn't, and who tests less than four times daily, the direct cost comparison argument fails, and due to the behaviour differences, providing them with a Libre doesn't mean that it will change their behaviour. There's much more required than that.
This is why what we really need is a study that takes a number of these people who test really irregularly (say a sample of 250) and give them all Libres for free for six months with appropriate training, and then see where we end up after that period of time. If we see a statistically significant change in behaviour and clinical outcomes, then you can see why the NHS would benefit. If we don't then it's back to the drawing board.
That there might be, but there's also a very large amount of research gone into the sensor biodynamics and the trials to make sure it works. It's not "just the cost of the reader components".I would prefer the NHS to stop funding these drug companies to have their executives on big wages. Why cant the NHS not command a massive discount with Abbot for these Libre? I am a computer programmer and I would say theres probably like £5-£10 of components in one of those meters
Very little is sold on a cost plus basis, but on a perceived value, or what the market will stand. There's a thing in business called the S curve, where price is plotted against the introduction timescales. Early adopters pay most, as a product picks up the price comes down, eventually reaching maturity where price will be at commodity level.I would prefer the NHS to stop funding these drug companies to have their executives on big wages. Why cant the NHS not command a massive discount with Abbot for these Libre? I am a computer programmer and I would say theres probably like £5-£10 of components in one of those meters
I would prefer the NHS spent its money on cancer treatments, resources and emergency care. And dietary advice - providing it was better advice than is provided now.
If more money is going to be spent on diabetes, i would prefer that it went on education.
Very little is sold on a cost plus basis, but on a perceived value, or what the market will stand. There's a thing in business called the S curve, where price is plotted against the introduction timescales. Early adopters pay most, as a product picks up the price comes down, eventually reaching maturity where price will be at commodity level.
I did read somewhere that iPhones cost a few 10s of dollars to make, but r&d has to be paid for and the market will stand a premium price.
I imagine we agreed in the early adopter phase still for the libre.
I to struggle to justify the cost, but am very close to making the decision based on many factors. I'm a geek, T1, would appreciate a better view of BG levels than I get with finger pricks. So a mix of all the factors discussed.
Funnily enough, I was very sorry keenI know my daughter wouldn't want one. I've already asked her if she'd like one and she said she didn't like the idea of having the sensor stuck to her all the time. Same answer for a pump.
I know my daughter wouldn't want one. I've already asked her if she'd like one and she said she didn't like the idea of having the sensor stuck to her all the time. Same answer for a pump.
Personally I would reduce strip usage for type 1s and invest that into these new, better technologiesSo for those who think the Freestyle Libre should be free on the NHS; where will the funds for this come from?
Bear in mind, the NHS can't afford glucose monitors for type 2s and junior doctors are already working for less than minimum wage...
Yes I agree with education in that sense. However, DSNs & consultants are given the space to only offer pumps to T1s that can 'manage' pumps (as well as fitting NICE clinical criteria) - why not entrust them with similar responsibility on CGM-type technologies?My point of view is that the cost of Libre is t in the device itself but in the education required to get people using it properly. The 5000 plus people on the Facebook group have a lot of people that struggle with interpreting what they see and making changes, so even with Libre or CGM education is still required.
Personally, the issue isn't, for me, whether or not they are available. It's that if its not on the NHS then the prices are exorbitant. We need a model whereby the beneficial extras can be obtained at a lower cost whilst retaining critical and essential care for free.
After 30 years of injecting I rejected the offer of a pump. I was persuaded and have never looked backI know my daughter wouldn't want one. I've already asked her if she'd like one and she said she didn't like the idea of having the sensor stuck to her all the time. Same answer for a pump.
The low number of signatures isn't necessarily because of a lack of support, I expect it's more because of a lack of awareness of the petition. That's why I've now joined this forum – to raise awareness so then at least if the number of signatures are low, it's not because of a lack of awarenessHi Jason, I was surprised to see so few signatures and surprised that so few folk considered it to be useful - I've found it amazing - really helps me prevent highs and lows ( rather than correcting them after the event) and is really helping me learn what works for my body and what doesn't. That's why I posted the original post ( but then stayed out of the debate). I find the Abbott Freestyle Libre Facebook page really helpful.
I could manage my type 1 without blood tests, but I wouldn't live very long....I stand by what I said. The NHS is strapped for cash as it is. Fact.
A Libre is NOT an essential part of diabetes care. If it was, those of us without one wouldn't be able to manage our diabetes every day.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?